University of California, San Diego (UCSD) and Genentech, Inc. Scientists Develop Potentially Disruptive Antibody Sequencing Technology

UCSD -- San Diego, CA, December 18, 2008 -- Bioinformatics researchers at the University of California, San Diego and Genentech have developed a new, quicker way to sequence monoclonal antibodies – a process that is many times faster than the sequencing technology typically used by academic and industry researchers today.

MORE ON THIS TOPIC